Myfortic 180 mg gastro-resistant tablets clinical trials

BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

This study is testing a new medicine, Tegoprubart, to see if it can help prevent the body from rejecting a new kidney after a transplant. Researchers will compare it to standard treatments to check how safe and effective it is.